comprehensive -WSS

comprehensive

author：comprehensive 2025-10-01 14:19:36 - browse：2

A liver with a smooth and healthy left half and a bumpy, browning right half — chronic disease coverage from STAT — Adobe

Akero Therapeutics said Monday that extending treatment with its experimental drug for the liver disease known as MASH from six months to two years resulted in better outcomes for patients — most notably reductions in liver scarring at a rate three times higher than placebo without worsening other symptoms.

The mid-stage study of the Akero drug called efruxifermin achieved its main goal in September 2022. With longer treatment, more patients with MASH responded to the drug, while those who initially benefited showed durable improvements.

“We’re really pleased with the data. It’s exactly what we were hoping to see,” said Kitty Yale, Akero’s chief development officer, in an interview with STAT. “It’s not just the high response rates, but the fact that responses are sustained and broadened as well.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

WSS

Today's health inequities arise from racist U.S. history, say experts

Carbon Health diabetes program, a test of data

Element Biosciences CEO lays out genome sequencing strategy

Cell therapy fails to slow type 1 diabetes, but safety is established

NIH chief: government has fallen behind pharma on clinical trials

What is STAT's opinion section for?

entertainment

comprehensive

explore

After affirmative action ruling, medical educators look to 'holistic review'

FTC falls short on scrutinizing hospital mergers, study says

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Carbon Health diabetes program, a test of data

Jerome Adams on the need for new antivirals for Covid

Healthy food access boosts outcomes in two studies

Apple is now the first public company to be valued at $3 trillion

Ohio still needs to do more to protect the right to abortion

Peter Hotez and the public health issue of online harassment

H5N1 bird flu virus started spreading in cows in Texas in December

entertainment

MultiPlan and major insurers sued for alleged medical price

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Melinda French Gates resigns from Gates Foundation

Why rehabilitation engineers need to center patients in their research

Key Senate committee drafts bipartisan bill to stem drug shortages

A letter from the executive editor: STAT UnitedHealth investigation

hotspot

focus

focus

hotspot